China's brain-computer interface industry is racing ahead
2 days ago
- #Neurotechnology
- #Brain-Computer Interface
- #China Tech
- China's BCI industry is transitioning from research to commercialization, supported by policy, clinical trials, and investment.
- Provinces like Sichuan, Hubei, and Zhejiang have set medical service pricing for BCI, aiding its inclusion in national insurance.
- Phoenix Peng, founder of NeuroXess and Gestala, sees BCI evolving from medical use to human augmentation.
- China's BCI roadmap targets technical milestones by 2027, industry standards by 2030, and global competitiveness.
- Four key drivers of China's BCI progress: policy support, clinical resources, industrial manufacturing, and strategic investment.
- China completed its first fully implanted, wireless BCI trial, a milestone in the field.
- BCI startups in China are challenging U.S. leaders, with the market projected to grow significantly by 2040.
- Two main BCI types: invasive (precise but risky) and noninvasive (safer but less precise).
- Emerging BCI technologies include ultrasound, magnetoencephalography, and hybrid methods.
- Noninvasive BCI solutions, like those from Gestala, target chronic pain, stroke, and depression.
- China is expected to align BCI regulations with international standards, focusing on data sovereignty and ethics.